- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥26.3b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥56.61
7D
-10.0%
1Y
-25.3%
PharmaResources (Shanghai)
Market Cap: CN¥4.6b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥25.56
7D
-8.4%
1Y
-14.1%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.7b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥23.80
7D
-4.1%
1Y
-28.6%
AcrobiosystemsLtd
Market Cap: CN¥8.9b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥53.46
7D
1.7%
1Y
2.0%
Xiamen Amoytop Biotech
Market Cap: CN¥24.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥60.63
7D
0.9%
1Y
-19.7%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.1b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥13.09
7D
3.6%
1Y
-20.4%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.6b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥43.95
7D
7.5%
1Y
-1.8%